| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | $0 | +1,871 | +25% | $0.000000 | 9,388 | 09 Feb 2024 | Direct | F1 |
| transaction | OGN | Common Stock | Tax liability | $12,069 | -740 | -7.9% | $16.31 | 8,648 | 09 Feb 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -1,871 | -100% | $0.000000* | 0 | 09 Feb 2024 | Common Stock | 1,871 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. |
| F2 | On each of February 9, 2022, February 9, 2023, and February 9, 2024, one-third of the RSUs vested. |